Literature DB >> 6477781

Acute haemodynamic effects of felodipine during beta blockade in patients with coronary artery disease.

W Culling, M S Ruttley, D J Sheridan.   

Abstract

The acute effects of felodipine on left ventricular function and haemodynamics were studied in 11 patients with coronary artery disease. To block reflex sympathetic activation due to peripheral vasodilatation and to avoid effects secondary to changes in heart rate all patients received a standard regimen of beta adrenoceptor blockade and all measurements were made during sinus rhythm and right atrial pacing. At 30 minutes after an oral dose (0.075 mg/kg in solution) felodipine plasma concentration were 16.4 (3.5) nmol/l. A significant fall in systemic vascular resistance (30%) and increase in cardiac index (30%) occurred, whereas pulmonary vascular resistance was unchanged. Felodipine increased left ventricular ejection fraction and mean velocity of circumferential fibre shortening but had no effect on derivates of left ventricular pressure (dP/dt or dP/dt P-1) during sinus rhythm or pacing. Thus at the dosage used felodipine was a potent dilator of systemic arterioles but had no direct effect on left ventricular function.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6477781      PMCID: PMC481655          DOI: 10.1136/hrt.52.4.431

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  6 in total

1.  Mean velocity of fiber shortening. A simplified measure of left ventricular myocardial contractility.

Authors:  J S Karliner; J H Gault; D Eckberg; C B Mullins; J Ross
Journal:  Circulation       Date:  1971-09       Impact factor: 29.690

2.  Measurement of left ventricular volumes in man by single-plane cineangiocardiography.

Authors:  I S Kasser; J W Kennedy
Journal:  Invest Radiol       Date:  1969 Mar-Apr       Impact factor: 6.016

3.  Interaction of the antihypertensive drug felodipine with calmodulin.

Authors:  S L Bostróm; B Ljung; S Mårdh; S Forsen; E Thulin
Journal:  Nature       Date:  1981-08-20       Impact factor: 49.962

4.  Haemodynamic effects of a new vasodilator drug, felodipine, in healthy subjects.

Authors:  G Johnsson; G Murray; A Tweddel; I Hutton
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

5.  Acute and chronic haemodynamic and electrophysiological effects of nifedipine in patients receiving atenolol.

Authors:  E Rowland; P Razis; D Sugrue; D M Krikler
Journal:  Br Heart J       Date:  1983-10

6.  Nifedipine and left ventricular function in beta-blocked patients.

Authors:  P I Joshi; J J Dalal; M S Ruttley; D J Sheridan; A H Henderson
Journal:  Br Heart J       Date:  1981-04
  6 in total
  36 in total

1.  Acute haemodynamic effects of cromakalim in patients with angina pectoris.

Authors:  P Thomas; M S Dixon; S J Winterton; D J Sheridan
Journal:  Br J Clin Pharmacol       Date:  1990-03       Impact factor: 4.335

2.  The effects of felodipine in angina pectoris.

Authors:  A R Lorimer; P MacFarlane; S Pringle; M P Barbour; Y Fox; T D Lawrie
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 3.  Calcium antagonists and chronic cardiac failure.

Authors:  M J Kendall; R C Horton; S R Smith
Journal:  Postgrad Med J       Date:  1986-08       Impact factor: 2.401

4.  Short and long term treatment of essential hypertension with felodipine as monotherapy.

Authors:  K Harrington; P Fitzgerald; P O'Donnell; K W Hill; E O'Brien; K O'Malley
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 5.  Aspects on the benefit-risk balance of felodipine in hypertension.

Authors:  D Elmfeldt; S Westerling
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 6.  Felodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.

Authors:  E Saltiel; A G Ellrodt; J P Monk; M S Langley
Journal:  Drugs       Date:  1988-10       Impact factor: 9.546

7.  Beneficial effects of felodipine on myocardial and coronary function during low-flow ischemia and reperfusion.

Authors:  E A Bernstein; F R Eberli; A M Silverman; G L Horowitz; C S Apstein
Journal:  Cardiovasc Drugs Ther       Date:  1996-05       Impact factor: 3.727

Review 8.  Felodipine clinical pharmacokinetics.

Authors:  P H Dunselman; B Edgar
Journal:  Clin Pharmacokinet       Date:  1991-12       Impact factor: 6.447

9.  Glucose tolerance in hypertensive patients during treatment with the calcium antagonist, felodipine.

Authors:  T Hedner; D Elmfeldt; H Von Schenck; E Sjögren; U Smith
Journal:  Br J Clin Pharmacol       Date:  1987-08       Impact factor: 4.335

10.  Felodipine ER formulation in the treatment of mild hypertension: efficacy and tolerability vs placebo.

Authors:  A Bossini; C Di Veroli; G Cavallotti; V Cagli
Journal:  Br J Clin Pharmacol       Date:  1990-10       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.